BLRX
BioLineRX
BLRX
BLRX
28 hedge funds and large institutions have $1.36M invested in BioLineRX in 2022 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 7 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
57% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 7
Holders
28
Holding in Top 10
–
Calls
$49K
Puts
–
Top Buyers
| 1 | +$29K | |
| 2 | +$20K | |
| 3 | +$18.9K | |
| 4 |
GWM
Geneos Wealth Management
Englewood,
Colorado
|
+$10.8K |
| 5 |
Citigroup
New York
|
+$4K |
Top Sellers
| 1 | -$96K | |
| 2 | -$60K | |
| 3 | -$27.9K | |
| 4 |
Morgan Stanley
New York
|
-$24.7K |
| 5 |
LPL Financial
San Diego,
California
|
-$23.1K |